About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Epilepsy Clinical Trials in Philadelphia | 133 Studies

Clinical Trials EpilepsyPhiladelphia

Epilepsy Clinical Trials in Philadelphia

Find 133 clinical trials for epilepsy near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Epilepsy trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 133 trials

CompletedProof of Principle for a Diagnostic Blood Test of Recurrent SeizuresThe primary goal of this observational study is to establish the accuracy of CNS-specific Assay for Recurrent Paroxysmal Events (CARPE) as a diagnostic blood test for epilepsy.NCT02269397·Philadelphia, Pennsylvania CompletedA Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.This trial will evaluate the efficacy and safety of brivaracetam (at doses of 5, 20 and 50 mg/day in twice a day administration) as add-on therapy in subjects with focal epilepsy.NCT00175825·Phoenix, Arizona and 41 others

Epilepsy Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingNeonatal Seizure Registry, GEnetics of Post-Neonatal EpilepsyThe NSR-GENE study is a longitudinal cohort study of approximately 300 parent-child trios from the Neonatal Seizure Registry and participating site outpatient clinics that aims to…NCT05361070·San Francisco, California and 7 others

Active not recruitingA Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset EpilepsyThe purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.NCT06132893·Phoenix, Arizona and 103 others

CompletedLamotrigine Extended-Release In Elderly Patients With EpilepsyThis study is being conducted to determine the safety and tolerability of lamotrigine (LTG) in elderly patients with epilepsy.NCT00516139·Birmingham, Alabama and 62 others

CompletedStudy With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset SeizuresThis trial will evaluate the efficacy and safety of ucb 44212 as add on therapy in subjects with focal epilepsy.NCT00152451·Little Rock, Arkansas and 6 others

CompletedPediatric Epilepsy StudyThis study will evaluate the safety and effectiveness of oxcarbazepine (Trileptal) as monotherapy in the treatment of partial seizures in pediatric patients 1 month to 3 years of…NCT00050947·Birmingham, Alabama and 29 others

CompletedA Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset SeizuresThis study evaluated the efficacy and safety of two trough-ranges of everolimus given as adjunctive therapy in patients with tuberous sclerosis complex (TSC) who had refractory…NCT01713946·Birmingham, Alabama and 103 others

TerminatedNatural History Study of Infants and Children With Developmental and Epileptic EncephalopathiesThis is a multicenter, prospective, 2-year observational study in infants and children with developmental and epileptic encephalopathies (DEEs).NCT04537832·Los Angeles, California and 15 others

CompletedStudy of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency DisorderA clinical study to evaluate the efficacy, safety, and tolerability of adjunctive ganaxolone therapy compared to placebo for the treatment of seizures in children and young adults…NCT03572933·Phoenix, Arizona and 35 others

CompletedPivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal EpilepsyThis is a multiple site, randomized, double blinded parallel-group controlled study.NCT04770337·Phoenix, Arizona and 31 others

CompletedBrivaracetam Efficacy and Safety Study in Subjects With Partial Onset SeizuresThis study will evaluate the efficacy and safety of brivaracetam at doses of 100 and 200mg/day compared to placebo as adjunctive treatment in adult focal epilepsy subjects with…NCT01261325·Phoenix, Arizona and 206 others

CompletedPatients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice VersaPharmacokinetic (PK) study to characterize changes in serum concentrations in epilepsy patients when switching from LAMICTAL immediate-release to extended-release and vice versa.NCT00264615·Anniston, Alabama and 11 others

CompletedConversion to Monotherapy Study With Keppra XR for Partial SeizuresThe primary objective of this study is to assess the efficacy of two doses of Keppra XR compared with a historical control as the placebo, in the monotherapy treatment of partial…NCT00419094·Dothan, Alabama and 44 others

CompletedTrial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset SeizuresThe objective of this historical-controlled trial is to demonstrate the efficacy and safety of conversion to Lacosamide monotherapy in subjects with Partial-onset Seizures who are…NCT00520741·Alabaster, Alabama and 157 others

CompletedPreventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis ComplexStudy design is a Phase IIb prospective multi-center, randomized, placebo-controlled, double-blind clinical trial.NCT02849457·Birmingham, Alabama and 12 others

TerminatedLong-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence SeizuresThe primary purpose of this study is to assess the long-term safety and tolerability of Cannabidiol Oral Solution (CBD) in pediatric participants with treatment-resistant…NCT03355300·Miami, Florida and 8 others

CompletedA Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet SyndromeStudy 1 and Study 3 are the prospective, merged analyses of 2 identical double-blind, placebo-controlled studies, ZX008-1501 and ZX008-1502, to assess the efficacy, safety, and…NCT02682927·Phoenix, Arizona and 54 others

RecruitingAn Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut SyndromeThis is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCL (EPX-100) as adjunctive therapy in…NCT05066217·Little Rock, Arkansas and 70 others

CompletedStudy Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal EpilepsyThis is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy.NCT06377930·New Haven, Connecticut and 11 others

PreviousPage 3 of 7Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia